<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Mon, 24 Nov 2025 16:34:51 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Palantir's Deal Frenzy: 26 Partnerships Across 15 Sectors  â€” And No Sign Of Slowing</title><link>https://www.benzinga.com/markets/tech/25/11/49043011/palantirs-deal-frenzy-26-partnerships-across-15-sectors-and-no-sign-of-slowing</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/24/Palantir-Technologies.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Palantir Technologies Inc (PLTR) expanded rapidly in 2025 with 26 partnerships and 15 sectors. Despite valuation debate. read more</description><pubDate>Mon, 24 Nov 2025 20:24:18 GMT</pubDate></item><item><title>Celestica Shares Rise 3.7% To Intraday High After Key Trading Signal</title><link>https://www.benzinga.com/Opinion/25/11/49042942/celestica-shares-rise-to-intraday-high-after-key-trading-signal</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/24/image.png?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>A key trading signal flashed for Celestica stock at a price of $306.70, after which CLS rose as much as 3.7% to an intraday high. read more</description><pubDate>Mon, 24 Nov 2025 20:21:52 GMT</pubDate></item><item><title>$1000 Invested In Royal Caribbean Gr 5 Years Ago Would Be Worth This Much Today</title><link>https://www.benzinga.com/insights/news/25/11/49042802/1000-invested-in-royal-caribbean-gr-5-years-ago-would-be-worth-this-much-today</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>read more</description><pubDate>Mon, 24 Nov 2025 20:15:39 GMT</pubDate></item><item><title>Axon Enterprise's Options: A Look at What the Big Money is Thinking</title><link>https://www.benzinga.com/insights/options/25/11/49042475/axon-enterprises-options-a-look-at-what-the-big-money-is-thinking</link><image_url>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Mon, 24 Nov 2025 20:01:55 GMT</pubDate></item><item><title>Here's How Much $1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today</title><link>https://www.benzinga.com/insights/news/25/11/49042401/heres-how-much-1000-invested-in-regeneron-pharmaceuticals-20-years-ago-would-be-worth-today</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>read more</description><pubDate>Mon, 24 Nov 2025 20:00:46 GMT</pubDate></item></channel></rss>